Adalimumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00051 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hidradenitis suppurativa | TxGNN Knowledge Graph |
| 2 | spondyloarthropathy | TxGNN Knowledge Graph |
| 3 | dyshidrosis | TxGNN Knowledge Graph |
| 4 | inflammatory bowel disease | TxGNN Knowledge Graph |
| 5 | rheumatoid arthritis | TxGNN Knowledge Graph |
| 6 | Crohn disease | TxGNN Knowledge Graph |
| 7 | psoriatic arthritis | TxGNN Knowledge Graph |
| 8 | ulcerative colitis (disease) | TxGNN Knowledge Graph |
| 9 | hidradenitis | TxGNN Knowledge Graph |
| 10 | juvenile arthritis due to defect in LACC1 | TxGNN Knowledge Graph |
| 11 | non-infectious uveitis | TxGNN Knowledge Graph |
| 12 | ankylosing spondylitis | TxGNN Knowledge Graph |
| 13 | Crohn's colitis | TxGNN Knowledge Graph |
| 14 | juvenile idiopathic arthritis | TxGNN Knowledge Graph |
| 15 | spondyloarthropathy, susceptibility to | TxGNN Knowledge Graph |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.